Trials / Sponsors / Nicholas Fidelman, MD
Nicholas Fidelman, MD
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastatic Malignant Neoplasm in the Liver, Neuroendocrine Neoplasm | Phase 2 | 2018-08-27 |
| Completed | Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases Colorectal Neoplasms, Neuroendocrine Tumors, Cholangiocarcinoma | Phase 2 | 2010-05-01 |